Summaries & Associations of Study Results
TR-338 Erythromycin Stearate
Target Organs and Levels of Evidence
NTP Technical Report Number 338
Produced from Chemtrack Database 09/19/01
| CHEMICAL/ CAS NUMBER | PEER REVIEW DATE | PRIMARY USES | ROUTE/EXPOSURE LEVELS | STUDY LABORATORY |
|---|---|---|---|---|
| ERYTHROMYCIN STEARATE 643-22-1 |
07/14/87 | ANTIBACTERIAL AGENT. (TDB) | Dosed-Feed R: 0,5000,10000 M: 0,2500,5000 PPM/50 PER GROUP | Physiological Research Laboratory |
| LEVELS OF EVIDENCE OF CARCINOGENICITY--ORGAN/TISSUE (NEOPLASM): | ||||
| MR: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | LIVER: GRANULOMA 1/50 2/50 10/50 | |||
| FR: NO EVIDENCE | ||||
| NON-NEOPLASTIC LESIONS: | LIVER: GRANULOMA 18/50 27/50 43/50 | |||
| MM: NO EVIDENCE | ||||
| FM: NO EVIDENCE | ||||
Web page last updated on February 10, 2006
